Michael A Metzger Insider Trading
Get free email notifications about insider trading for Michael A Metzger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael A Metzger. Michael A Metzger is a Director in CTI BIOPHARMA CORP ($CTIC) and a Director in RESPONSE GENETICS INC ($RGDX) and a President and COO in Syndax Pharmaceuticals Inc ($SNDX).
Address: C/O RESPONSE GENETICS, INC 1640 MARENGO ST., 6TH FLOOR LOS ANGELES 90033 CA
Companies in which Michael A Metzger is an Insider
CTI BIOPHARMA CORP
Trading Symbol: CTICIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael A Metzger: Director
Holdings: 20,121 shares
Current Value: $93,965
Latest Transaction: Mar 12 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RESPONSE GENETICS INC
Trading Symbol: RGDXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Michael A Metzger: Director
Holdings: 1,000 shares
Latest Transaction: Aug 01 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Trading Symbol: SNDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael A Metzger: President and COO
Holdings: 32,659 shares
Current Value: $283,807
Latest Transaction: Feb 05 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael A Metzger
Sentiment: All, CTIC, RGDX, SNDX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 3.30 | 80,000 | 264,000 | 80,000 | |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 21.36 | 160,000 | 3,417,600 | 160,000 | |
Feb 03 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | M | 7.20 | 15,000 | 108,000 | 0 | |
Feb 03 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Sell | S | 20.19 | 15,000 | 302,799 | 17,659 | 32.7 K to 17.7 K (-45.93 %) |
Feb 03 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Buy | M | 7.20 | 15,000 | 108,000 | 32,659 | 17.7 K to 32.7 K (+84.94 %) |
Nov 06 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | M | 7.20 | 100,000 | 720,000 | 0 | |
Nov 06 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Sell | S | 20.31 | 100,000 | 2,031,410 | 17,659 | 117.7 K to 17.7 K (-84.99 %) |